IP-6.

IP-6 is inositol hexaphosphate, the same molecule as dietary phytate. Its six phosphate groups bind divalent zinc tightly at intestinal pH and form insoluble complexes the gut cannot take up. The phytate-to-zinc molar ratio is the standard measure used in nutrition science precisely because this competition is so consistent. Taking IP-6 away from zinc-containing meals or supplements is the practical response.

Phytate is the single strongest known dietary inhibitor of non-heme iron absorption. Even small amounts in a meal cut iron uptake substantially, and the effect scales with the phytate-to-iron ratio. IP-6 supplements deliver concentrated phytate, so the interaction is more pronounced than with whole grains. Anyone managing low iron status should keep the two well separated in time.

Ascorbate reduces ferric iron to the ferrous form and holds it in a soluble chelate that phytate competes for less effectively. In practice this partially offsets phytate's block on non-heme iron when both are present in the same meal. The rescue is partial, not complete, and it does not apply to zinc. It is one of the few reliable counters to phytate's mineral effect.

Phytase hydrolyses phosphate groups off IP-6, stepping it down through IP5, IP4 and lower forms that bind minerals far more weakly. Adding phytase alongside an IP-6 supplement works directly against whatever the IP-6 was included for. The two belong in different products, not the same one. In food processing this same reaction is used deliberately to raise mineral bioavailability.

Myo-inositol is the carbon backbone of IP-6, and intestinal and cellular phosphatases interconvert the phosphorylated forms. Commercial IP-6 products commonly pair the two on the reasoning that free inositol supports the cellular inositol phosphate pool. What proportion of oral IP-6 is absorbed intact rather than dephosphorylated first is not well established. Read the pairing as mechanistic rather than clinical.

Magnesium is a divalent cation and binds phytate on the same phosphate groups that trap zinc and calcium. The affinity is lower than for zinc but the effect is real at supplement-level phytate doses. Magnesium status is rarely the concern that zinc status is, but the interaction belongs on the label. Separating doses by two hours reduces overlap.

Copper binds phytate with high affinity, and concentrated IP-6 reduces its intestinal uptake. Copper intakes are typically modest to begin with, so an added absorption barrier matters more than the raw affinity number suggests. The interaction is the same chemistry that gives IP-6 its metal-chelating character in the first place. Dose separation applies.

Manganese forms complexes with phytate in the intestinal lumen and its absorption falls accordingly. This is part of the general pattern rather than anything specific to manganese. It is worth listing because manganese is present in most multivitamins that might sit alongside an IP-6 product.

Ferrous sulfate is the classic non-heme iron supplement and it is precisely the form phytate blocks most effectively. Co-administration wastes a meaningful fraction of the iron dose. Anyone taking iron on a schedule should keep IP-6 to a different part of the day. Adding ascorbate to the iron dose recovers part but not all of the loss.